These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 25087653)
1. Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression? Schipmann S; Wermker K; Schulze HJ; Kleinheinz J; Brunner G J Craniomaxillofac Surg; 2014 Dec; 42(8):1827-33. PubMed ID: 25087653 [TBL] [Abstract][Full Text] [Related]
2. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma. Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174 [TBL] [Abstract][Full Text] [Related]
3. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. Al-Qahtani D; Anil S; Rajendran R J Oral Pathol Med; 2011 Sep; 40(8):636-42. PubMed ID: 21352381 [TBL] [Abstract][Full Text] [Related]
4. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes. Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594 [TBL] [Abstract][Full Text] [Related]
6. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265 [TBL] [Abstract][Full Text] [Related]
7. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545 [TBL] [Abstract][Full Text] [Related]
8. Local immune response in cutaneous basal cell carcinoma. Omland SH Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891 [TBL] [Abstract][Full Text] [Related]
9. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis. Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458 [TBL] [Abstract][Full Text] [Related]
10. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study. Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744 [TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453 [TBL] [Abstract][Full Text] [Related]
12. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561 [TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells in oral squamous cell carcinoma. Liu S; Liu D; Li J; Zhang D; Chen Q J Oral Pathol Med; 2016 Oct; 45(9):635-639. PubMed ID: 27084296 [TBL] [Abstract][Full Text] [Related]
14. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes. Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277 [TBL] [Abstract][Full Text] [Related]
15. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388 [TBL] [Abstract][Full Text] [Related]
16. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703 [TBL] [Abstract][Full Text] [Related]
17. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area. Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490 [TBL] [Abstract][Full Text] [Related]
19. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917 [TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients. Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z Digestion; 2012; 86(4):329-37. PubMed ID: 23207161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]